BHI up +1.41% percent Today $BHI High is at 66.49 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
BHI up +1.41% percent Today $BHI High is at 66.49 and the Low 65.63 with current volume of 5,358,919.

Recent News posted below.

Baker Hughes Inc BHI other info.
http://investorshangout.com/Baker-Hughes-Inc-BHI-50288/

BHI Baker Hughes Inc Recent Headline News

What Is Great For Baker Hughes And Schlumberger May Be Just Ok For Halliburton
Richard Zeits - at Seeking Alpha - 25 mins ago

HAL: 49.11 (-0.12), WFT: 16.23 (-0.25), SLB: 95.75 (+0.12), BHI: 64.86 (-0.37)

Most active New York Stock Exchange-traded stocks
AP - 27 mins ago
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
KMI: 40.45 (+0.20), F: 15.50 (-0.04), GE: 26.94 (+0.33), ABX.TO: 14.80 (+0.73), K.TO: 3.26 (+0.21), ABX: 13.10 (+0.63), PFE: 30.64 (+0.32), HAL: 49.11 (-0.12), BAC: 17.15 (+0.06), AGN: 214.04 (+4.84), YRI.TO: 4.75 (+0.26), KGC: 2.90 (+0.19), DNR: 10.03 (+0.02), TWTR: 40.45 (-0.02), AUY: 4.20 (+0.23), BHI: 64.86 (-0.37)

NYSE stocks posting largest percentage increases
AP - 27 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
AEC: 21.49 (+0.12), TSE: 15.27 (+0.72), PVG.TO: 7.00 (+0.37), FR.TO: 6.15 (+0.37), WMS: 23.92 (+1.48), TSN: 42.29 (-0.74), PVG: 6.19 (+0.32), SEA.TO: 9.09 (+0.84), AG: 5.44 (+0.33), TEX: 29.79 (+1.51), SA: 8.00 (+0.69), PBYI: 225.33 (+13.78), BHI: 64.86 (-0.37)

Halliburton needed to be bigger and stronger, CEO Lesar says
Seeking Alpha - at Seeking Alpha - 1 hr 15 mins ago

HAL: 49.11 (-0.12), BHI: 64.86 (-0.37)

Will Baker Hughes (BHI) Stock React Today to Investigation Into Merger Deal?
at The Street - 1 hr 38 mins ago
Baker Hughes (BHI) is being investigated by law firm Levi & Korsinsky regarding the sale of the company to Halliburton (HAL).
HAL: 49.11 (-0.12), BHI: 64.86 (-0.37)

National-Oilwell Varco: Generate Income In Uncertain Market
at The Street - 2 hrs 38 mins ago
By Alex Gavrish, Etalon Investment Research; author of "Wall Street Back To Basics" Halliburton and Baker Hughes’s merger After yesterdays announcement that Halliburton Company (NYSE:HAL) an...
NOV: 72.41 (+0.59), GE: 26.93 (+0.32), HAL: 49.11 (-0.12), BHI: 64.86 (-0.37)

BHI INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Baker Hughes Inc. in Connection With the Fairness of the Sale of the Company to Halliburton Co. -- BHI
PR Newswire - 2 hrs 45 mins ago
Levi & Korsinsky is investigating the Board of Directors of Baker Hughes Inc. ("Baker Hughes" or "the Company" (NYSE: BHI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Halliburton Company.
BHI: 64.86 (-0.37)

Update: Halliburton Agrees To Buy Baker Hughes
Stone Fox Capital - at Seeking Alpha - Tue Nov 18, 9:52AM CST

HAL: 49.11 (-0.12), BHI: 64.86 (-0.37)

Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 9:10AM CST
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 214.04 (+4.84), ACT: 267.61 (+19.67), EOG: 98.24 (+1.89), HAL: 49.11 (-0.12), HP: 78.62 (+0.37), MRO: 32.14 (+0.32), BHI: 64.86 (-0.37)

Critical Alerts For Kinder Morgan, Celldex Therapeutics, Baker Hughes Inc., RF Micro Devices and SolarCity Released By InvestorsObserver
PR Newswire - Tue Nov 18, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for KMI, CLDX, BHI, RFMD and SCTY.
KMI: 40.45 (+0.20), SCTY: 55.90 (+2.31), CLDX: 17.48 (-0.77), RFMD: 14.00 (+0.65), BHI: 64.86 (-0.37)

Halliburton-Baker Hughes Mega-Merger: Deal Sealed at $35B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 8:15AM CST
After days of speculation and the recent hostile bid, Halliburton Co. (HAL) and its smaller rival Baker Hughes Inc. (BHI) confirmed that they have entered into a merger agreement.
HAL: 49.11 (-0.12), WFT: 16.22 (-0.26), SLB: 95.76 (+0.13), BHI: 64.86 (-0.37)

Downgrade Alert for Baker Hughes (BHI)
Comtex SmarTrend(R) - Tue Nov 18, 7:55AM CST
Baker Hughes (NYSE:BHI) was downgraded from Buy to Hold at Argus Research today. The stock closed yesterday at $65.23 on volume of 69.6 million shares, above average daily volume of 6.9 million. Baker Hughes (NYSE:BHI) has potential upside of 8.9% based on a current price of $65.23 and analysts' consensus price target of $71.04. The stock should hit resistance at its 200-day moving average (MA) of $65.64, as well as support at its 50-day MA of $58.86.
BHI: 64.85 (-0.38)

Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
PR Newswire - Tue Nov 18, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), Apple (NASDAQ:AAPL), Gilead Sciences (NASDAQ:GILD), Kinder Morgan (NYSE:KMI), and Alibaba (NYSE:BABA).
KMI: 40.45 (+0.20), GILD: 103.31 (+2.87), HAL: 49.11 (-0.12), AAPL: 115.26 (+1.27), BABA: 111.71 (-2.54), BHI: 64.85 (-0.38)

Cramer's Mad Money - Globalstar Defends Itself (11/17/14)
SA Editor Miriam Metzinger - Seeking Alpha - Tue Nov 18, 5:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday November 17. CEO Interview Jay Monroe, Globalstar (NYSEMKT: GSAT ) Jay Monroe, CEO of Globalstar ( GSAT ) appeared on Mad Money to defend the company...
CST: 42.85 (+0.94), WHR: 177.11 (+1.56), MPC: 94.20 (+1.69), HAL: 49.11 (-0.12), TSN: 42.27 (-0.76), SHW: 240.12 (+0.81), GSAT: 2.59 (-0.21), REGN: 412.34 (+12.69), LULU: 45.35 (+0.93), BHI: 64.86 (-0.37)

'Fast Money' Recap: Stay Short the Yen Following Japan's GDP Miss
at The Street - Tue Nov 18, 4:00AM CST
The trading panel discussed Japan's surprising announcement and whether Twitter is a better bet than Facebook or LinkedIn.
CST: 42.85 (+0.94), AMZN: 325.30 (+2.25), GE: 26.93 (+0.32), FB: 74.43 (+0.19), HAL: 49.11 (-0.12), WMT: 83.78 (+0.21), TLT: 119.51 (+0.32), SLB: 95.76 (+0.13), LNKD: 223.26 (-0.02), SUNE: 20.85 (+4.24), TGT: 66.89 (-0.24), CVS: 90.16 (+0.04), GOOGL: 545.77 (-0.87), TWTR: 40.45 (-0.02), GDX: 20.14 (+0.75), BHI: 64.86 (-0.37)

Be Careful With Baker Hughes After The Merger-Related Rally
Stone Fox Capital - at Seeking Alpha - Tue Nov 18, 2:37AM CST

WFT: 16.22 (-0.26), HAL: 49.11 (-0.12), SLB: 95.76 (+0.13), BHI: 64.86 (-0.37)

We Think Baker Hughes Offers A Unique Opportunity
Orange Peel Investments - at Seeking Alpha - Tue Nov 18, 12:53AM CST

HAL: 49.11 (-0.12), BHI: 64.86 (-0.37)

Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us
at The Street - Mon Nov 17, 7:09PM CST
Cramer says this morning's losses and afternoon's gains prove that not all markets need to trade in tandem.
CST: 42.85 (+0.94), BIIB: 305.22 (+2.80), GE: 26.93 (+0.32), NKE: 96.36 (+0.30), HAL: 49.11 (-0.12), TSN: 42.27 (-0.76), GSAT: 2.59 (-0.21), LULU: 45.35 (+0.93), AGN: 214.04 (+4.84), MACK: 9.01 (+0.39), WHR: 177.11 (+1.56), UA: 69.21 (+0.32), DSX: 7.89 (+0.07), ALNY: 91.23 (+2.25), MPC: 94.20 (+1.69), JCP: 7.35 (+0.09), SHW: 240.12 (+0.81), MBLY: 47.44 (+0.46), REGN: 412.34 (+12.69), BHI: 64.86 (-0.37)

Investors sour on Halliburton deal after big premium paid for Baker Hughes
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 6:11PM CST

HAL: 49.11 (-0.12), SLB: 95.76 (+0.13), BHI: 64.86 (-0.37)

Acquisition of Baker Hughes Incorporated (BHI) by Halliburton Company (HAL) May Not Be in Shareholders' Best Interests
PR Newswire - Mon Nov 17, 5:56PM CST
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Baker Hughes Incorporated (NYSE: BHI) by Halliburton Company (NYSE: HAL). On November 17, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Halliburton will acquire Baker Hughes. Under the terms of the agreement, Baker Hughes shareholders will receive $78.62 for each share of Baker Hughes common stock.
HAL: 49.11 (-0.12), BHI: 64.86 (-0.37)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 3

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Updated Category News Views 7

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Continue Reading
NYC's Carriage Horse Ban: A New Era for Urban Welfare

Updated Category News Views 4

You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...

Continue Reading
Basic Invite's Holiday Card Service Offers Saving Time

Updated Category News Views 1

Getting the Cards Out: Maneuvering the Holiday Hustle Alright, let's dive into the madness that is holiday card season. Could be a logistical nightmare or a nostalgic tradition, depending on your cup of tea. Basic Invite here is trying to cut through the chaos by bumping deadlines and offering some straight-out-the-gate mailing options. If you play your cards right—pun...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Celebrating Alexander Trost: A Lifetime of Compassionate Care

Updated Category News Views 4

A Legendary Career in Palliative Medicine You know, in a world where people glamorize stock flips and flashy earnings, it's refreshing to spotlight good old-fashioned compassion. Enter Dr. Alexander Trost, DNP, FNP-C, ACHPN. This fella has just been honored as a Pinnacle Lifetime Member by The Inner Circle—a nod to his impactful work in palliative medicine. You ever try...

Continue Reading
Tigo Energy Faces Class Action Over Revenue Claims

Updated Category News Views 3

Trouble Brewing for Tigo Energy? Straight from the horse's mouth, we hear about Tigo Energy (NASDAQ: TYGO) getting embroiled in a class action smackdown. Picture it: Tigo fumbles their projections, and boy does it sting. They're caught in the crossfire for allegedly puffing up their revenue expectations tied to a venture with EG4 Electronics—poised to churn out...

Continue Reading
Rising Food Safety Stars Honored: A Global Effort

Updated Category News Views 2

Food Safety Breakthrough: Youth Leads the Charge When it comes to food safety, it’s about time the younger crowd gets their due. The latest crew to step up to the plate is the Class of 2026's 40 Under 40 Food Safety Professionals. They’re not just pushing paper; these folks are setting the bar high and innovating across continents with real, tangible changes. From...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 5

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading

Top 5 Most Recently Viewed Articles

ComFree's Remarkable Comeback: A New Era in Real Estate

Updated Category News Views 375

ComFree's Return to the Market After a notable absence, ComFree is back, igniting excitement in the real estate industry. The company's founders, Erin and Travis Holowach, originally created ComFree as a platform for homeowners to sell properties without agent interference, saving them significant fees. Their mission is now revitalized as they reclaim the brand they built...

Continue Reading
Why Capital Gains Tax Planning Matters for Long-Term Investors

Updated Category Investing Views 159

The average federal income tax paid by a typical person ranges from 13.5% to 15%, and tax planning is a mathematical necessity for anyone serious about building long-term wealth in the United States. Every dollar lost to an inefficient exit from an investment is a dollar that stops compounding for your future self. There are thousands of taxable events triggered daily...

Continue Reading
Biomea Fusion Reports Milestone 52-Week Findings in Diabetes

Updated Category News Views 164

Biomea Fusion Unveils Promising Efficacy of Icovamenib Biomea Fusion, Inc. (Nasdaq: BMEA), a pioneer in clinical-stage advancements for diabetes and obesity, recently announced significant 52-week results from its Phase II COVALENT-111 study. This study examined the potential effects of icovamenib, a novel treatment for type 2 diabetes (T2D), and the results underscore a...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 23

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Groundbreaking Debut of DeriW Exchange at Exclusive Event

Updated Category News Views 309

Groundbreaking Launch of DeriW Exchange DeriW, an innovative decentralized perpetual exchange, has officially launched during an exclusive event, showcasing its advanced features and capabilities. The event, hosted by CoinW, attracted 400 influential figures from the cryptocurrency sector. Among the attendees were thought leaders, blockchain pioneers, and affiliates, all...

Continue Reading